121TiPKEYNOTE-756: Randomized, double-blind, phase III study of pembrolizumab vs placebo + neoadjuvant chemotherapy (CT) and adjuvant endocrine therapy (ET) for high-risk, early-stage estrogen receptor–positive human epidermal growth factor receptor 2–negative (ER+/HER2−) breast cancer (BC)

Cardoso, F ; Jia, L ; Hirshfield, K ; Karantza, V

Oxford University Press

Texto completo disponível

132P The psychological impact of the COVID-19 pandemic on patients with early breast cancer

Almeida, S. ; Frasquilho, D. ; Cotovio, G. ; Viana, F. ; Sousa, B. ; Oliveira, J. ; Mattson, J. ; Marzorati, C. ; Roziner, I. ; Karademas, E. ; Kolokotroni, E. ; Stamatakos, G.S. ; Mazzocco, K. ; Pat-Horenczyk, R. ; Poikonen-Saksela, P. ; Cardoso, F. ; Oliveira-Maia, A.

European Society for Medical Oncology. Published by Elsevier Ltd

Texto completo disponível

135MO HRQoL with neoadjuvant pembrolizumab + chemotherapy vs placebo + chemotherapy, followed by adjuvant pembrolizumab vs placebo for early-stage TNBC: Results from KEYNOTE-522

Dent, R.A. ; Cortés, J. ; Pusztai, L. ; McArthur, H.L. ; Kuemmel, S. ; Bergh, J. ; Denkert, C. ; Park, Y.H. ; Hui, R. ; Harbeck, N. ; Takahashi, M. ; Untch, M. ; Fasching, P.A. ; Cardoso, F. ; Haiderali, A. ; Jia, L. ; Nguyen, A.M. ; Pan, W. ; O'Shaughnessy, J. ; Schmid, P.

Texto completo disponível

1604P Global survey of 104 cancer patient organisations reveals devastating impact of COVID-19

Reid, F. ; Cardoso, F. ; Filicevas, A. ; Warwick, L. ; Isaacson, J. ; Spiegel, A. ; Baugh, E. ; Fox, J. ; Oliver, K. ; Giles, R. ; MacKay, C.E.

Elsevier Ltd

Texto completo disponível

164P Current use of breast cancer multigene signatures in clinical practice among European experts: Results from the PROCURE Project

Curigliano, G. ; Cardoso, F. ; Gnant, M.I. ; Harbeck, N. ; King, J. ; Laenkholm, A-V. ; Penault-Llorca, F. ; Prat, A.

Texto completo disponível

1759P Cancer care during COVID-19: Data from 157 patient organisations

Giles, R.H. ; Baugh, E. ; Cardoso, F. ; Filicevas, A. ; Fox, J. ; Oliver, K. ; Reid, F. ; Spiegel, A. ; Warwick, L. ; MacKay, C.

Elsevier Ltd

Texto completo disponível

175P Alpelisib (ALP) + endocrine therapy (ET) in patients (pts) with PIK3CA-mutated, hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2–) advanced breast cancer (ABC): Subgroup analyses from the BYLieve study

Cardoso, F. ; Juric, D. ; Lerebours, F. ; Krop, I. ; Ruiz Borrego, M. ; Neven, P. ; Park, Y.H. ; Yardley, D. ; Jhaveri, K. ; Arce, C. ; Gu, E. ; Akdere, M. ; Rugo, H.S.

Elsevier Ltd

Texto completo disponível

178P Assessment of side effects (SEs) impacting quality of life (QoL) in patients (pts) undergoing treatment (tx) for advanced breast cancer (ABC) in clinical practice: A real-world (RW) multi-country survey

Cardoso, F. ; Rihani, J. ; Aubel, D. ; de Courcy, J. ; Harmer, V. ; Harbeck, N. ; Casas, A. ; Rugo, H.S. ; Fasching, P.A. ; Haftchenary, S. ; Pathak, P. ; Schumacher-Wulf, E.

Elsevier Ltd

Texto completo disponível

187P Development of a patient-centered core outcome set for metastatic breast cancer

de Ligt, K.M. ; de Rooij, B.H. ; Hedayati, E. ; Karsten, M.M. ; Smaardijk, V.R. ; Velting, M. ; Saunders, C. ; Travado, L. ; Cardoso, F. ; López Ramírez, E. ; Carney, N.C. ; Wengstrom, Y. ; Ives, A. ; Velikova, G. ; Sousa Fialho, M.D.L. ; Koppert, L. ; Van De Poll-Franse, L.V.

Elsevier Ltd

Texto completo disponível

193OAn international update of the EORTC questionnaire for assessing quality of life in breast cancer patients (EORTC QLQ-BC23) - EORTC QLQ-BR45

Bjelic-Radisic, V ; Bottomley, A ; Cardoso, F ; Cameron, D ; Brain, E ; Kuljanic, K ; de Costa, R A ; Conroy, T ; Inwald, E ; Serpentini, S ; Pinto, M ; Weis, J ; Morag, O ; Guro Lindviksmoen Astrup, G ; Tomaszweksi, K ; Pogoda, K ; Sinai, P ; Sprangers, M A G ; Aaronson, N ; Greimel, E

Oxford University Press

Texto completo disponível